T. Rowe Price Associates’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.14B | Sell |
|
|||||
|
2025
Q1 | $3.98B | Sell |
|
|||||
|
2024
Q4 | $3.92B | Buy |
|
|||||
|
2024
Q3 | $5.28B | Sell |
|
|||||
|
2024
Q2 | $6.31B | Sell |
|
|||||
|
2024
Q1 | $6.08B | Sell |
|
|||||
|
2023
Q4 | $5.62B | Sell |
|
|||||
|
2023
Q3 | $5.24B | Sell |
|
|||||
|
2023
Q2 | $5.38B | Sell |
|
|||||
|
2023
Q1 | $6.1B | Buy |
|
|||||
|
2022
Q4 | $6.53B | Buy |
|
|||||
|
2022
Q3 | $4.88B | Buy |
|
|||||
|
2022
Q2 | $4.56B | Buy |
|
|||||
|
2022
Q1 | $4.3B | Sell |
|
|||||
|
2021
Q4 | $4.54B | Sell |
|
|||||
|
2021
Q3 | $3.66B | Sell |
|
|||||
|
2021
Q2 | $4.66B | Sell |
|
|||||
|
2021
Q1 | $4.55B | Buy |
|
|||||
|
2020
Q4 | $3.84B | Sell |
|
|||||
|
2020
Q3 | $3.68B | Sell |
|
|||||
|
2020
Q2 | $3.74B | Buy |
|
|||||
|
2020
Q1 | $3.08B | Buy |
|
|||||
|
2019
Q4 | $3.48B | Sell |
|
|||||
|
2019
Q3 | $2.85B | Sell |
|
|||||
|
2019
Q2 | $4.79B | Sell |
|
|||||
|
2019
Q1 | $5.53B | Sell |
|
|||||
|
2018
Q4 | $5.18B | Buy |
|
|||||
|
2018
Q3 | $5.08B | Sell |
|
|||||
|
2018
Q2 | $4.42B | Buy |
|
|||||
|
2018
Q1 | $3.99B | Buy |
|
|||||
|
2017
Q4 | $3.8B | Buy |
|
|||||
|
2017
Q3 | $2.74B | Buy |
|
|||||
|
2017
Q2 | $2.55B | Buy |
|
|||||
|
2017
Q1 | $2.16B | Sell |
|
|||||
|
2016
Q4 | $1.98B | Sell |
|
|||||
|
2016
Q3 | $1.87B | Sell |
|
|||||
|
2016
Q2 | $2.72B | Sell |
|
|||||
|
2016
Q1 | $3.42B | Sell |
|
|||||
|
2015
Q4 | $3.6B | Buy |
|
|||||
|
2015
Q3 | $3.28B | Buy |
|
|||||
|
2015
Q2 | $2.57B | Buy |
|
|||||
|
2015
Q1 | $1.79B | Buy |
|
|||||
|
2014
Q4 | $656M | Buy |
|
|||||
|
2014
Q3 | $588M | Buy |
|
|||||
|
2014
Q2 | $443M | Buy |
|
|||||
|
2014
Q1 | $397M | Sell |
|
|||||
|
2013
Q4 | $484M | Sell |
|
|||||
|
2013
Q3 | $475M | Buy |
|
|||||
|
2013
Q2 | $281M | Buy |
|